4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1710-1492
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry ; volume:13 ; number:1 ; day:26 ; month:7 ; year:2017 ; pages:1-6 ; date:12.2017
Allergy, asthma and clinical immunology ; 13, Heft 1 (26.7.2017), 1-6, 12.2017
- Keyword
-
Atemwegskrankheit
Atemnot
- Creator
-
Snelder, S. M.
- Contributor
-
Weersink, E. J. M.
Braunstahl, G. J.
SpringerLink (Online service)
- DOI
-
10.1186/s13223-017-0206-9
- URN
-
urn:nbn:de:1111-2017100615588
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Snelder, S. M.
- Weersink, E. J. M.
- Braunstahl, G. J.
- SpringerLink (Online service)
Other Objects (12)
Severe asthma and the omalizumab option
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung
Omalizumab-Therapie bei Jugendlichen mit schwerem allergischem Asthma – eine Anwendungsbeobachtung
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
Comparison of extended intervals and dose reduction of omalizumab for asthma control
Omalizumab: clinical use for the treatment of an adolescent with difficult asthma
Severe asthma and the omalizumab option
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung
Omalizumab-Therapie bei Jugendlichen mit schwerem allergischem Asthma – eine Anwendungsbeobachtung
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
Comparison of extended intervals and dose reduction of omalizumab for asthma control
Omalizumab: clinical use for the treatment of an adolescent with difficult asthma
Severe asthma and the omalizumab option
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung
Omalizumab-Therapie bei Jugendlichen mit schwerem allergischem Asthma – eine Anwendungsbeobachtung
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Poster 1012: Safety and efficacy of omalizumab in 10 children with asthma and other allergic comorbidities
Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
Comparison of extended intervals and dose reduction of omalizumab for asthma control